Zobrazeno 1 - 10
of 261
pro vyhledávání: '"gastrointestinal side effects"'
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Background Heterotopic ossification (HO) is a frequent complication of joint trauma or surgery, commonly occurring after hip replacements, acetabular or other joint injuries, or surgeries. Indomethacin has long been used to prevent HO and is
Externí odkaz:
https://doaj.org/article/b5986c8bfc4944b097c4da151383184f
Autor:
Rowa Al Ramahi, Deema Tumeh
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Many old people have at least one chronic disease. As a result, multiple drugs should be used. Gastrointestinal complications may occur because of the harmful effects of these chronic drugs on the stomach. The study aimed to asses
Externí odkaz:
https://doaj.org/article/619ba5da061148f4880f7ccba37b920f
Autor:
Anne Hong, Damien Bolton, Trung Pham, David Angus, David Pan, Daryl Lim Joon, Alwin Tan, Kevin McMillan, Yee Chan, Paul Manohar, Joe Thomas, Huong Ho, Peter Orio, Emily Holt, Margaret Cokelek, Nathan Lawrentschuk, Farshad Foroudi, Michael Chao
Publikováno v:
Société Internationale d’Urologie Journal, Vol 5, Iss 2, Pp 111-121 (2024)
Objectives: Our objective was to assess the rate of complications and gastrointestinal adverse effects of rectal spacer insertion for salvage post prostatectomy radiation therapy. Methods: A retrospective observational study was performed. Between Se
Externí odkaz:
https://doaj.org/article/c4be7124b27743eb9dba6f7107be8edb
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 1, Pp 191-212 (2024)
Amidst the obesity and type II diabetes mellitus (T2DM) epidemics, glucagon-like peptide-1 receptor agonists (GLP-1RAs) stand out as a promising therapeutic ally, achieving notable success in glycemic control and weight management. While GLP-1RAs’
Externí odkaz:
https://doaj.org/article/0751c95b5d3448ae963f06647be628fe
Autor:
Brittney Lager, Jacob Liseno, Ivan Božin, Sarah M. England, Sai L. Shankar, Jason P. Mendoza, James B. Lewin
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 2199-2203 (2023)
Externí odkaz:
https://doaj.org/article/f752573b25fa4a30838db3262a5c2fdd
Autor:
Hanna K. von Siebenthal, Sara Gessler, Florence Vallelian, Joachim Steinwendner, Urs-Martin Kuenzi, Diego Moretti, Michael B. Zimmermann, Nicole U. Stoffel
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102286- (2023)
Summary: Background: Guidelines to treat iron deficiency recommend daily provision of oral iron, but this may decrease fractional iron absorption and increase side effects. Our objective was to compare consecutive-day versus alternate-day iron supple
Externí odkaz:
https://doaj.org/article/628bd28bfd6645a5820f45e50dda2c27
Autor:
Brittney Lager, Jacob Liseno, Ivan Božin, Sarah M. England, Sai L. Shankar, Jason P. Mendoza, James B. Lewin
Publikováno v:
Neurology and Therapy, Vol 12, Iss 1, Pp 145-159 (2022)
Abstract Introduction Adherence to disease-modifying therapies is key for achieving optimal outcomes in multiple sclerosis (MS). Diroximel fumarate (DRF) is an oral fumarate approved for treatment of relapsing forms of MS. It has the same pharmacolog
Externí odkaz:
https://doaj.org/article/f512ef3b56f34173b2ff3a4b8030b0a5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dubravka Bobek, Andrea Banić Stipetić, Miljenko Franić, Marko Lucijanić, Jelena Lucijanić, Ana Gudelj Gračanin, Luciana Mijačika, Porin Perić
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss 4, Pp 588-597 (2022)
This study aimed to determine whether patients with active rheumatoid arthritis (RA) regularly take non-steroidal anti-inflammatory drugs (NSAIDs) and to clarify whether their decision to take NSAIDs depends on disease activity, intensity of pain,
Externí odkaz:
https://doaj.org/article/31554f46117c4b21af24c8dc4db7809d
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
AimTo identify risk factors predictive of or associated with gastrointestinal side effects (GISE) of liraglutide in patients with type 2 diabetes (T2DM).MethodsT2DM patients treated with liraglutide for the first time were obtained and grouped into p
Externí odkaz:
https://doaj.org/article/ea288b6426b24ae5b18a683ebf29d869